The table below shows Design Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$0.00
$0.00
-
-
-
$226.00K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$59.13M
$44.35M
$57.06M
$48.61M
$24.78M
$6.06M
SG&A
$20.34M
DSGN annual revenue (10-K history)
Design Therapeutics, Inc. reported annual revenue of $0.00 for fiscal year 2025. Figures come from the company's audited annual reports as filed with the SEC.